[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Otoshi et al., 2019 - Google Patents

Possible biomarkers for cancer immunotherapy

Otoshi et al., 2019

View HTML
Document ID
5004983492797200280
Author
Otoshi T
Nagano T
Tachihara M
Nishimura Y
Publication year
Publication venue
Cancers

External Links

Snippet

Immune checkpoint inhibitors (ICIs) have drastically changed the clinical care of cancer. Although cancer immunotherapy has shown promise in various types of malignancies, thus far, the proportion of patients who can benefit from ICIs is relatively small. Immune-related …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06QDATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10Services
    • G06Q50/22Health care, e.g. hospitals; Social work
    • GPHYSICS
    • G06COMPUTING; CALCULATING; COUNTING
    • G06FELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data

Similar Documents

Publication Publication Date Title
Otoshi et al. Possible biomarkers for cancer immunotherapy
El-Sayes et al. Tumor heterogeneity: a great barrier in the age of cancer immunotherapy
Onoi et al. Immune checkpoint inhibitors for lung cancer treatment: a review
Temraz et al. Gut microbiome: a promising biomarker for immunotherapy in colorectal cancer
Tunger et al. The evolving landscape of biomarkers for anti-PD-1 or anti-PD-L1 therapy
Wojas-Krawczyk et al. Beyond PD-L1 markers for lung cancer immunotherapy
Cesano et al. Bringing the next generation of immuno-oncology biomarkers to the clinic
Pagni et al. Targeting immune-related biological processes in solid tumors: we do need biomarkers
Kaderbhaï et al. The role of molecular profiling to predict the response to immune checkpoint inhibitors in lung cancer
Shindo et al. Novel biomarkers for personalized cancer immunotherapy
Valenti et al. Precision medicine and melanoma: multi-omics approaches to monitoring the immunotherapy response
Olbryt et al. Biological factors behind melanoma response to immune checkpoint inhibitors
Mulet-Margalef et al. Challenges and therapeutic opportunities in the dMMR/MSI-H colorectal cancer landscape
Cabel et al. Limited sensitivity of circulating tumor DNA detection by droplet digital PCR in non-metastatic operable gastric cancer patients
Sesma et al. From tumor mutational burden to blood T cell receptor: looking for the best predictive biomarker in lung cancer treated with immunotherapy
Cimas et al. Genomic mapping identifies mutations in RYR2 and AHNAK as associated with favorable outcome in basal-like breast tumors expressing PD1/PD-L1
Ros et al. Immunotherapy for colorectal cancer with high microsatellite instability: the ongoing search for biomarkers
Moisseev et al. Transcriptomic and genomic testing to guide individualized treatment in chemoresistant gastric cancer case
Busse et al. Immunoprofiling in neuroendocrine neoplasms unveil immunosuppressive microenvironment
Ulase et al. Gastric carcinomas with stromal B7-H3 expression have lower intratumoural CD8+ T cell density
Sillo et al. The gut microbiome, microsatellite status and the response to immunotherapy in colorectal cancer
Narasimhan et al. Profiling of adipose and skeletal muscle in human pancreatic cancer cachexia reveals distinct gene profiles with convergent pathways
Thouvenin et al. Complete response in metastatic clear cell renal cell carcinoma patients treated with immune-checkpoint inhibitors: remission or healing? How to improve patients’ outcomes?
Tang et al. Identification of CD73 as a novel biomarker encompassing the tumor microenvironment, prognosis, and therapeutic responses in various cancers
Emmelot et al. SARS-CoV-2 omicron BA. 4/BA. 5 mutations in spike leading to T cell escape in recently vaccinated individuals